Rezolute
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rezolute and other ETFs, options, and stocks.About RZLT
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism.
CEONevan Charles Elam
CEONevan Charles Elam
Employees71
Employees71
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2010
Founded2010
Employees71
Employees71
RZLT Key Statistics
Market cap166.92M
Market cap166.92M
Price-Earnings ratio-1.94
Price-Earnings ratio-1.94
Dividend yield—
Dividend yield—
Average volume18.18M
Average volume18.18M
High today$1.85
High today$1.85
Low today$1.30
Low today$1.30
Open price$1.46
Open price$1.46
Volume35.29M
Volume35.29M
52 Week high$11.46
52 Week high$11.46
52 Week low$1.07
52 Week low$1.07
Stock Snapshot
The current Rezolute(RZLT) stock price is $1.68, with a market capitalization of 166.92M. The stock trades at a price-to-earnings (P/E) ratio of -1.94.
During the trading session on 2025-12-15, Rezolute(RZLT) shares reached a daily high of $1.85 and a low of $1.30. At a current price of $1.68, the stock is +29.2% higher than the low and still -9.2% under the high.
Trading activity shows a volume of 35.29M, compared to an average daily volume of 18.18M.
The stock's 52-week range extends from a low of $1.07 to a high of $11.46.
The stock's 52-week range extends from a low of $1.07 to a high of $11.46.
Analyst ratings
60%
of 10 ratingsBuy
60%
Hold
40%
Sell
0%
People also own
Based on the portfolios of people who own RZLT. This list is generated using Robinhood data, and it’s not a recommendation.